The U.S. Food and Drug Administration today allowed marketing of the
inFlow Intraurethral Valve-Pump, a replaceable urinary prosthesis for
use in female adults who cannot contract the muscles necessary to push
urine out of the bladder (impaired detrusor contractility or IDC). IDC
is a condition where patients are unable to spontaneously urinate due
to insufficient bladder muscle contraction, which can result from
significant neurologic disease or injury such as stroke, multiple
sclerosis, spinal cord injury, spina bifida or diabetic neuropathy. Read more
|